Search

The article focuses on the clinical case of a 49-year-old scuba diver who experiences vestibular symptoms. It recalls the first episode of the patient that occurred following a routine dive in which he experienced symptoms such as hearing loss, rotary vertigo and vomiting. It explores the results of several tests done on the patient which include electronystagmography, computed tomography and metabolic examination. It is concluded that diving did not cause reversible inner ear dysfunction in the patient.

The article details a treatment approach to the case of a 46-year-old man who presented with a four-month history of tinnitus. The patient was placed on risedronate 30 milligrams (mg) twice weekly plus daily supplementation with calcium/vitamin D, vitamin D3 and fluoride. At follow up three months later, etidronate 400 mg daily for two of every six weeks was added to the continued medical regimen and risedronate was discontinued. Treatment was then changed at another follow up so that etidronate was taken for two of every eight weeks.

The article focuses on the case of a young girl presented with a 2-month history of painful aural fullness bilaterally, rotary vertigo, nausea and severe headache. The patient did not experience any symptoms when she awoke in the morning, but minor symptoms were experienced during the day. The results of the sinusoidal vertical-axis rotation testing at 18 months are tackled. It cites clinical points being shown by the case, one of which is that a recurrence of symptoms driven by menarche may be encountered by a young girl in such a situation.

The article focuses on a 57-year-old male singer who was diagnosed with monaural diplacusis with tinnitus, aural fullness, hyperacusis and senosrineural hearing loss. It relates that the neurotologic testing with tuning forks found diplacusis at 512, 2,048 and 4,096 hertz (Hz). It notes that the patient was placed on an alternating regimen of etidronate 400 milligram (mg)/day for 2 weeks and risedronate 30 mg two times weekly for 4 weeks. It cites that the man reported that the diplacusis was better toward the end of the etidronate cycle.